Evidence map›Paper›PMID 40732119›Full record

ReviewMicroorganisms2025

Investigating the Antimicrobial Activity of Anuran Toxins.

Manuela B Pucca, Anne Grace A C Marques, Ana Flávia M Pereira, Guilherme Melo-Dos-Santos, Felipe A Cerni, Beatriz C S Jacob, Isabela G Ferreira, Rafael L Piccolo, Marco A Sartim, Wuelton M Monteiro and 1 more

Abstract readReview
In one paragraph

Review in Microorganisms, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Manuela B PuccaDepartment of Clinical Analysis, School of Pharmaceutical Sciences, São Paulo State University (UNESP), Araraquara 14800-903, SP, Brazil.ORCID 0000-0003-2594-7068
Anne Grace A C MarquesPost Graduate Program in Tropical Medicine (PPGMT), Amazonas State University, Manaus 69065-001, AM, Brazil.
Ana Flávia M PereiraThe Center for the Study of Venoms and Venomous Animals (CEVAP), São Paulo State University (UNESP), Botucatu 18619-002, SP, Brazil.ORCID 0000-0002-2925-8545
Guilherme Melo-Dos-SantosGraduate Program in Bioscience and Biotechonology Applied to Pharmacy, School of Pharmaceutical Sciences, São Paulo State University (UNESP), Araraquara 19060-900, SP, Brazil.
Felipe A CerniMedical School, Federal University of Roraima (UFRR), Boa Vista 69310-000, RR, Brazil.
Beatriz C S JacobDepartment of BioMolecular Sciences, School of Pharmaceutical Sciences of Ribeirão Preto, University of São Paulo, Ribeirão Preto 19040-903, SP, Brazil.
Isabela G FerreiraDepartment of BioMolecular Sciences, School of Pharmaceutical Sciences of Ribeirão Preto, University of São Paulo, Ribeirão Preto 19040-903, SP, Brazil.
Rafael L PiccoloDepartment of Clinical Analysis, School of Pharmaceutical Sciences, São Paulo State University (UNESP), Araraquara 14800-903, SP, Brazil.
Marco A SartimPost Graduate Program in Tropical Medicine (PPGMT), Amazonas State University, Manaus 69065-001, AM, Brazil.ORCID 0000-0003-4572-3109
Wuelton M MonteiroPost Graduate Program in Tropical Medicine (PPGMT), Amazonas State University, Manaus 69065-001, AM, Brazil.ORCID 0000-0002-0848-1940
Isadora S OliveiraDepartment of BioMolecular Sciences, School of Pharmaceutical Sciences of Ribeirão Preto, University of São Paulo, Ribeirão Preto 19040-903, SP, Brazil.ORCID 0000-0002-2036-1191

Funding

Coordenação de Aperfeicoamento de Pessoal de Nível Superior GMSFundação de Amparo à Pesquisa do Estado de São Paulo 2020/13176-3Fundação de Amparo à Pesquisa do Estado de São Paulo 2023/09921-3Fundação de Amparo à Pesquisa do Estado de São Paulo 2023/11264-0Fundação de Amparo à Pesquisa do Estado de São Paulo 2024/14618-0Fundação de Amparo à Pesquisa do Estado de São Paulo 2024/17849-3Fundação de Amparo à Pesquisa do Estado do Amazonas 001/2023Fundação de Amparo à Pesquisa do Estado do Amazonas 020/2024National Council for Scientific and Technological Development 151190/2023-2National Council for Scientific and Technological Development 307184/2020-0National Council for Scientific and Technological Development 309207/2020-7
6 · The paper itself

Abstract

Anurans, commonly known as frogs and toads, comprise a diverse group of amphibians distributed across all continents except Antarctica. This manuscript provides a detailed overview of the global anuran fauna, emphasizing their biology, remarkable adaptations, and ecological importance. A particular focus is placed on their specialized cutaneous glands, which are crucial for defense, communication, and survival. These glands secrete a diverse array of bioactive compounds, including peptides, alkaloids, and other secondary metabolites, shaped by evolutionary pressures. Among these compounds, toxins with potent antimicrobial properties stand out due to their ability to combat a broad spectrum of microbial pathogens. We explore the chemical diversity of these secretions, analyzing their modes of action and their potential applications in combating antibiotic-resistant bacteria and other pathogens. By integrating knowledge, this study underscores the importance of anurans as both ecological keystones and a valuable resource for biotechnological innovations. Furthermore, it highlights the urgent need to conserve anuran biodiversity for harnessing their potential in the development of novel antimicrobial agents to address global health challenges.

Indexed as

alkaloidantimicrobial peptidesfrogtoad

Identifiers

PMID40732119
PMCPMC12298997

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.